Posts Tagged ‘ Drugwatch ’

In C.R. Bard Transvaginal Mesh Federal Trial Tempers Flare

Aug 1st, 2013 | By

With more than 27,000 cases naming six transvaginal mesh makers consolidated in a Charleston, West Virginia federal courtroom, the Donna Cisson v. C.R. Bard is the first to go to trial. The first Cisson trial, which began July 8, ended in a mistrial two days later. Drugwatch reports on the second day of testimony in
[continue reading...]



TVT-NO Founders Radio Interview on the Struggle to Help Others

Jul 30th, 2013 | By
TVT-NO Founders Radio Interview on the Struggle to Help Others

Teresa and David Sawyer of Ohio talk to DrugWatch Radio about how they established their nonprofit organization TVT-NO after Teresa received a Gynecare TVT Bladder Sling. She is still suffering. Teresa calls mesh a “genocide on women.” She and David talk about the FDA’s failure to protect the public, what women are being told today
[continue reading...]



The Future of Mesh Sales is Rosy Says Market Research Group

Apr 26th, 2012 | By
The Future of Mesh Sales is Rosy Says Market Research Group

April 24, 2012 ~ Even though the number of lawsuits against synthetic mesh manufacturers is growing by the day, surgical mesh products are expected to surge in sales in 2012, according to the Millennium Research Group (MRG). The group interviewed 181 U.S. surgeons (gynecologists, urologists and urogynecologists) in November and December of last year. Among
[continue reading...]



We hope you find this a helpful resource. National News Editor, Jane Akre, began MDND with the hope of providing the latest news, information and perspective from the regulatory, industry and patient point of view, something that goes under-reported in much of the coverage of medical devices. The public is just now becoming aware that many devices do not undergo the same scrutiny as prescription drugs and are instead grandfathered in under an FDA loophole that has gone largely unchanged since the 1970s. As a result, patients become the post-market clinical trial subjects, and many suffer devastating and permanent injuries.